ReviewDrugs2025
PI3K Inhibitors as Potential Therapeutic Agents for the Treatment of COPD with Associated Atherosclerosis.
Mario Cazzola et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ReviewDrugs2025
Mario Cazzola et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.